Lixte Biotechnology (LIXT) Institutional Ownership → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free LIXT Stock Alerts $2.46 +0.08 (+3.36%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Lixte Biotechnology (NASDAQ:LIXT)CurrentInstitutional OwnershipPercentage5.10%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$18.29KNumber ofInstitutional Sellers(last 12 months)0 Get LIXT Insider Trade Alerts Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LIXT Institutional Buying and Selling by Quarter Ad InvestorPlaceBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… Lixte Biotechnology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/5/2023 EP Wealth Advisors LLC2,211$786K0.0%N/A0.013% 2/9/2023 Ethos Financial Group LLC248,084$126K0.0%N/A1.490% 8/12/2022 Almanack Investment Partners LLC.248,084$185K0.0%-66.7%1.490% 11/9/2021 BlackRock Inc.13,425$28K0.0%+191.9%0.098% 11/4/2021 Almanack Investment Partners LLC.806,050$1.68M0.1%-17.9%5.863% 8/16/2021 State Street Corp33,600$102K0.0%N/A0.244% 8/16/2021 Sabby Management LLC65,511$199K0.0%-17.8%0.477% 8/13/2021 Renaissance Technologies LLC50,900$154K0.0%N/A0.370% 8/13/2021 Vanguard Group Inc.74,383$225K0.0%N/A0.544% 8/4/2021 Almanack Investment Partners LLC.982,046$2.98M0.3%-5.8%7.189% 5/21/2021 Citadel Advisors LLC23,813$79K0.0%N/A0.174% 5/18/2021 Citadel Advisors LLC23,813$79K0.0%N/A0.174% 5/11/2021 Almanack Investment Partners LLC.1,042,105$3.43M0.3%N/A7.698% 2/16/2021 Santa Monica Partners LP166,667$528K0.4%N/A1.347% (Data available from 1/1/2016 forward) LIXT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LIXT shares? During the previous two years, the following institutional investors and hedge funds held shares of Lixte Biotechnology shares: EP Wealth Advisors LLC ($786K), and Almanack Investment Partners LLC. ($185K), Ethos Financial Group LLC ($126K).Learn more on LIXT's institutional investors. What percentage of Lixte Biotechnology stock is owned by institutional investors? 5.10% of Lixte Biotechnology stock is owned by institutional investors. Learn more on LIXT's institutional investor holdings. Which institutional investors have been buying Lixte Biotechnology stock? The following institutional investors have purchased Lixte Biotechnology stock in the last 24 months: Ethos Financial Group LLC ($248.08K), and EP Wealth Advisors LLC ($2.21K). How much institutional buying is happening at Lixte Biotechnology? Institutional investors have bought a total of 250,295 shares in the last 24 months. This purchase volume represents approximately $1.28M in transactions. Which Lixte Biotechnology major shareholders have been selling company stock? The following institutional investors have sold Lixte Biotechnology stock in the last 24 months: Almanack Investment Partners LLC. ($496K). How much institutional selling is happening at Lixte Biotechnology? Institutional investors have sold a total of 496,000 shares in the last 24 months. This volume of shares sold represents approximately $3.69M in transactions. Related Companies: KA Major Shareholders ENVB Major Shareholders ADIL Major Shareholders PCSA Major Shareholders GNPX Major Shareholders SONN Major Shareholders ASLN Major Shareholders PULM Major Shareholders BFRI Major Shareholders VCNX Major Shareholders This page (NASDAQ:LIXT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.